Try our Advanced Search for more refined results

September 27, 2019

BI-LO, LLC et al v. Bausch Health Companies Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 30, 2019

    Glumetza Makers Slapped With 2 New Suits Over Price Hikes

    Pharmaceutical companies Bausch Health, Assertio, Salix, Santarus and Lupin now face at least five class actions alleging that they participated in a yearslong scheme that catapulted prices for diabetes drug Glumetza up to more than $3,000 for one month's supply.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login